William F. D'angelo, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |
Dr. Robert D Ecker, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-885-5851 |
Dr. Matthew R Sanborn, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring Street, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-885-5851 |
Dr. Susan Catherine Williams, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 92 Campus Dr Ste A, Scarborough, ME 04074 Phone: 207-885-0011 |
Jeffrey E Florman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |
Dr. George Roth, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |
Dr. Christopher James Neal, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 92 Campus Dr Fl 1, Scarborough, ME 04074 Phone: 207-885-0022 |
Joseph Tirone Alexander, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-0011 Fax: 207-885-5851 |
Konrad N.m. Barth, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |
Rajiv D. Desai, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 1st Floor, Scarborough, ME 04074 Phone: 207-885-4479 Fax: 207-883-2586 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Kaiser Health News staff writer Jordan Rau reports: "Medicare will levy $227 million in fines against hospitals in every state but one for the second round of the government's campaign to reduce the number of patients readmitted within a month, according to federal records released Friday" (Rau, 8/2).
In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles. This approach is known formally as "short-cycle structured intermittent antiretroviral therapy" (SIT) or colloquially as the "7-7" approach.
A new form of congenital muscular dystrophy has been discovered which is caused by mutations in a previously un-linked gene.
Knowledge and information empowers people facing a terminal diagnosis or end of life, delegates heard at the National Medicines Symposium in Brisbane last week.
› Verified 9 days ago